The global induced pluripotent stem cells market size is calculated at USD 2.13 billion in 2025 and is expected to reach ...

Conventional human pluripotent stem cells at the primed pluripotent state are capable of generating all the embryonic ...

Extraembryonic trophoblast lineages constitute the placenta, and are essential for individual development. In human early embryo development, these cells can be generated from totipotent blastomeres.

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...

Researchers have developed engineered heart muscle allografts from stem cells, showing promising results in repairing heart damage in primates and humans.

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-s ...

Pluristyx, the leading provider of innovative induced pluripotent stem cells (iPSC), announces the issuance of the groundbreaking induced Allogeneic Cell Tolerance (iACT Stealth™) U.S. Patent No.

A live webcast, if recorded, of each presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast ...

World-renowned stem cell scientists will gather in Kyoto, Japan for the International Society for Stem Cell Research (ISSCR) ...